èšåºæ®µéã®éºäŒåæ²»çäŒæ¥ã§ãã Genprex, Inc. ã¯ããããç³å°¿ç
ã®æ£è
ã«å¯Ÿããæ²»çæ³ã®éçºã«æ³šåããŠããŸããåç€Ÿã®æè¡ã¯ãçŸåšæ²»çã®éžæè¢ãéãããŠãããããç³å°¿ç
ã®æ£è
éå£ã«æ°ããæ²»çæ³ãæäŸããããã«ãç
æ°ãšéãéºäŒåãæäžããããã«èšèšãããŠããŸããå瀟ã¯ãæ°ããæ²»çæ³ãæäŸããããã«ãéºäŒåæ²»çã®ãã€ãã©ã€ã³ãããã«é²ããããã®åè£è¬ãéçºããããã«ãæ©é¢ãååè
ãšé£æºããŠããŸããäž»ãªè£œååè£ã¯ãéå°çްèèºãã (NSCLC) ã®æ²»çã®ããã®åèšåºæ®µéã«ãã REQORSA (GPX-001) ã§ããå瀟ã¯ãŸããç³å°¿ç
ã®åèšåºæ®µéã®éºäŒåæ²»çã§ãã GPX-002 ãéçºäžã§ããå瀟ã¯ãŸããããç²åééã·ã¹ãã ã§ãã ONCOPREX ãæäŸããŠããŸããGenprex, Inc. 㯠2009 幎ã«èšç«ããããããµã¹å·ãªãŒã¹ãã£ã³ã«æ¬ç€Ÿã眮ããŠããŸãã